Disselhorst, Maria J
The Netherlands Cancer Institute
2 papers on CoChatORCID 0000-0003-3532-4155
Most cited papers
- Verified
Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial
Disselhorst, M. J., Quispel-Janssen, J., Lalezari, F., Monkhorst, K., de Vries, J. F., van der Noort, V., Harms, E., Burgers, S., & Baas, P. (2019) · The Lancet Respiratory Medicine
Occupational and environmental lung diseasesCancer Immunotherapy and Biomarkers
Cited by 250
- Verified
Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials
Mankor, J. M., Disselhorst, M. J., Poncin, M., Baas, P., Aerts, J. G. J. V., & Vroman, H. (2020) · eBioMedicine
Cancer Immunotherapy and BiomarkersOccupational and environmental lung diseases
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free